What this study is
The goal of this clinical trial is to test the effects of a ketogenic diet on the progression and control of type 1 diabetes in children with newly diagnosed diabetes. The main questions to answer are:
- Does a ketogenic diet prolong the honeymoon period of type 1 diabetes?
- Does a ketogenic diet improve diabetes control?
- Is a ketogenic diet safe, acceptable and sustainable in children with newly diagnosed diabetes?
- What are the microbiome, inflammatory and metabolic changes linking diet to β-cell function?
Participants will receive a combination of free meals, groceries, micronutrient supplements, and intensive diet and diabetes education for 9 months.
- Diabetes care devices will be connected for cloud-based data collection.
- Bi-weekly data downloads and remote check-ins will assess dietary intake, satisfaction with diet and study procedures, and possible safety concerns.
- During four study visits held at at baseline, 1, 5, and 9 months, an intravenous catheter (IV) will be placed for collection of 5 blood samples before and up to 2 hours after a liquid test meal (protein shake) to assess insulin response. A stool sample will also be collected to assess microbiome changes.
- Children and their caregivers may be invited to participate in a semi-structured interview, and online questionnaires to assess their experience with the diet and diabetes care, general well-being and quality of life.
- Children and their caregivers may be invited to participate in a follow-up visit to evaluate long-term effects after 24 months.
Comparison will be made between a ketogenic vs standard diet.
What's being tested
- Ketogenic diet, food delivery and education
Intervention · OTHER
- Standard diet, food delivery and education
Intervention · OTHER
Both interventions
Meals and groceries will be delivered and participants will receive education on nutrition, meal preparation, and diabetes care strategies. Participants will consume study-prescribed foods exclusively.
Study details
- Official title
- Effect of Dietary Carbohydrate on Diabetes Control and Beta Cell Function in Children With Newly Diagnosed Diabetes
- Sponsor
- Boston Children's Hospital
- Conditions
- Diabetes Mellitus, Type 1
- Enrolling
- 52 people
- Starts
- 2024-05-31
- Est. completion
- 2029-04-30
- Design
- Single-blind, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 5 Years – 12 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Children aged 5 to 12 years.
- Within 3 month of diabetes diagnosis.
- Insulin adjusted HbA1c ≤9 if enrolled ≥ 2 months pat diagnosis.
- Type 1 diabetes confirmed by immediate insulin requirement and any 2 of the following criteria: autoimmunity marker [glutamate decarboxylase-65, islet-antigen-2, zinc transporter-8, insulin [prior to first insulin dose]; age under 10 years, BMI <95th percentile.
- Family committed and able to participate in study education and implement dietary intervention.
You can't join if
- Dietary needs or habits incompatible with the study meal plans, (e.g., vegan, major food intolerances/allergies, ketogenic).
- Eating disorders as assessed by Chede-Q8.
- Major medical illness or use of medications other than insulin that could interfere with metabolic or glycemic variables.
- Major psychiatric illness.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openBoston Children's Hospital
Boston, Massachusetts, United States
- Belinda Lennerz · Contact
Recruiting
Study team
Sponsor
Boston Children's Hospital
Study ID IRB-P00044330
Principal investigator
Belinda Lennerz
Boston Children's Hospital
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.